RMFCX | TRCVX | RMFCX / TRCVX | |
Total Expense Ratio | 0.91 | 0.30 | 303% |
Annual Report Gross Expense Ratio | 0.91 | 0.30 | 303% |
Fund Existence | 23 years | 23 years | - |
Gain YTD | 11.421 | 9.744 | 117% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 109B | 11.4B | 956% |
Annual Yield % from dividends | 1.24 | 1.54 | 80% |
Returns for 1 year | 7.71 | 10.20 | 76% |
Returns for 3 years | 32.16 | 33.96 | 95% |
Returns for 5 years | 56.41 | 66.17 | 85% |
Returns for 10 years | 91.12 | 91.60 | 99% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CAF | 15.51 | 0.18 | +1.17% |
Morgan Stanley China A Share Fund | |||
XHS | 99.52 | 0.20 | +0.20% |
SPDR® S&P Health Care Services ETF | |||
EMDV | 46.15 | 0.09 | +0.19% |
ProShares MSCI Emerg Mkts Div Growers | |||
NITE | 33.47 | 0.03 | +0.09% |
The Nightview ETF | |||
IAI | 170.73 | -3.17 | -1.82% |
iShares US Broker-Dealers&Secs Exchs ETF |